NLRP3 and early-onset autosomal dominant Alzheimer disease: In the central nervous system, the significant elevation of IL-1β in the cerebrospinal fluid of brain injury, Alzheimer’s disease, and multiple sclerosis depends on the activation of NLRP3 within microglia (Wang and Hauenstein 2020).